ClinicalTrials.gg
CompletedNCT07785778Updated Aug 25, 2026

Cluster Training in Female Volleyball Players

An interventional study of Traditional Resistance Training and Standard Cluster Resistance Training in Athletic Performance, Volleyball Players and Resistance Training, sponsored by Birjand University of Medical Sciences. Completed at 1 site in Iran. Open to female participants aged 18 Years to 30 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-25.

Sponsored by Birjand University of Medical Sciences · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Registered 3 years 8 months after the study started (first participant enrolled Nov 2022, registered Aug 2026).
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years to 30 Years
Sex
Female
01

Study summary

This study compares the effects of three different resistance training methods-traditional training, standard cluster training, and undulating cluster training-on strength, hormonal responses, and inflammation in female volleyball players aged 18-30 years. Thirty participants with at least two years of volleyball and resistance training experience were randomly assigned to one of three groups. All participants performed resistance training three times per week and volleyball-specific training two times per week for eight weeks. Blood samples were taken before and after the first session (acute response) and after eight weeks (chronic adaptation) to measure testosterone, cortisol, IGF-1, progesterone, and C-reactive protein (CRP). Performance tests included upper-body and lower-body strength (bench press and squat), speed, agility, and vertical jump. The main finding was that undulating cluster training produced significantly greater improvements in upper-body strength compared to standard cluster training, while all three methods were equally effective for lower-body strength and other performance measures. No significant differences were found between groups for hormonal or inflammatory changes. The study provides practical guidance for coaches seeking to optimize upper-body strength gains in female volleyball players.

Read the detailed description

This study compares the effects of three different resistance training methods-traditional training, standard cluster training, and undulating cluster training-on strength, hormonal responses, and inflammation in female volleyball players aged 18-30 years. Thirty participants with at least two years of volleyball and resistance training experience were randomly assigned to one of three groups. All participants performed resistance training three times per week and volleyball-specific training two times per week for eight weeks. Blood samples were taken before and after the first session (acute response) and after eight weeks (chronic adaptation) to measure testosterone, cortisol, IGF-1, progesterone, and C-reactive protein (CRP). Performance tests included upper-body and lower-body strength (bench press and squat), speed, agility, and vertical jump. The main finding was that undulating cluster training produced significantly greater improvements in upper-body strength compared to standard cluster training, while all three methods were equally effective for lower-body strength and other performance measures. No significant differences were found between groups for hormonal or inflammatory changes. The study provides practical guidance for coaches seeking to optimize upper-body strength gains in female volleyball players.

02

Conditions studied

  • Athletic Performance
  • Volleyball Players
  • Resistance Training

Keywords

  • Cluster
  • Configuration
03

In context

Lead sponsor

Birjand University of Medical Sciences is the lead sponsor of 7 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 30 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Female volleyball players aged 18 to 30 years

At least 2 years of continuous training in volleyball and resistance training

Complete health status (based on health and wellness questionnaire results)

No anterior cruciate ligament injury or other upper-/lower-extremity injuries in the past 6 months

Familiarity with basic resistance training techniques

Non-pregnant, with regular menstrual cycles

No regular use of medications (including oral )

No use of ergogenic supplements affecting muscle mass (e.g., anabolic steroids, growth hormone, or insulin-like substances) in the 6 months prior to the study

Exclusion criteria

Exclusion Criteria:

  • Absence from more than three consecutive training sessions

Any musculoskeletal injury that prevented continuation of the training program

Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraception

Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.

Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
30 participants (actual)

Study arms

  • Active comparator
    Traditional Resistance Training (TRT)

    Eight weeks of traditional resistance training, 3 sessions per week. Linear progression with 240s inter-set rest (weeks 1-3), 200s (weeks 4-5), 180s (weeks 6-8). Exercises: dumbbell thruster, power clean, back squat, deadlift, knee flexion curl, bench press, military press, lat pulldown

    Behavioral: Traditional Resistance Training

  • Experimental
    Standard Cluster Resistance Training (SCRT)

    Eight weeks of standard cluster resistance training, 3 sessions per week. Similar to TRT but with intra-set rest intervals (10-30s between clusters) to maintain movement quality and power output.

    Behavioral: Standard Cluster Resistance Training

  • Experimental
    Undulating Cluster Resistance Training (UCRT)

    Eight weeks of undulating cluster resistance training, 3 sessions per week. Combines intra-set rest with systematic weekly variations in load and repetition schemes, balancing neural drive and load tolerance

    Behavioral: Undulating Cluster Resistance Training

Interventions

  • BehavioralTraditional Resistance Training

    Eight weeks of traditional resistance training, 3 sessions per week. Each session includes 8 exercises: dumbbell thruster, power clean, back squat, deadlift, knee flexion curl, bench press, military p

  • BehavioralStandard Cluster Resistance Training

    Eight weeks of standard cluster resistance training, 3 sessions per week. Same exercises and intensity progression as TRT, but with intra-set rest intervals (10-30 seconds between clusters) to maintain movement quality, repetition velocity, and power output across multiple sets.

  • BehavioralUndulating Cluster Resistance Training

    Eight weeks of undulating cluster resistance training, 3 sessions per week. Combines intra-set rest intervals (10-30 seconds between clusters) with systematic weekly variations in load and repetition schemes. Intensity and volume undulate across weeks to balance neural drive and load tolerance while preserving high-quality repetitions.

06

What researchers measure

Primary outcomes

  1. Change in Relative Peak Power

    Relative peak power derived from the CMJ height and body mass, calculated using the Sayers equation: Peak power (W) = 60.7 × jump height (cm) + 45.3 × body mass (kg) - 2055.

    Time frame: baseline and after 8- week

Secondary outcomes

  1. Change in Lower-Body Strength (Squat 1-RM)

    Maximum dynamic strength of the lower body, measured using the estimated 1-repetition maximum (1-RM) test for the squat exercise. The 1-RM was estimated using the Brzycki formula based on the maximum weight participants could lift for 1-9 repetitions.

    Time frame: Baseline and 8 weeks

  2. Change in Speed (20-m Sprint)

    Sprint performance measured over a distance of 20 meters. Participants performed a maximal sprint, and the time was recorded in seconds.

    Time frame: baseline and after 8- week

  3. Change in Agility

    Agility performance measured using a standard agility test (e.g., T-test or similar). Participants performed the test, and the completion time was recorded in seconds.

    Time frame: baseline and after 8- week

  4. Change in Countermovement Jump (CMJ) Height

    Vertical jump height measured using a countermovement jump (CMJ) test. Participants performed 3 maximal jumps with 30-second rest intervals. The highest jump height (in centimeters) was recorded using a wall-mounted graduated tape. Peak power was then calculated using the Sayers equation.

    Time frame: baseline and after 8- week

  5. Change in Relative Peak Power

    Relative peak power derived from the CMJ height and body mass, calculated using the Sayers equation: Peak power (W) = 60.7 × jump height (cm) + 45.3 × body mass (kg) - 2055.

    Time frame: baseline and after 8- week

  6. Change in Serum Testosterone

    Serum levels of testosterone measured using commercial chemiluminescence immunoassay kits. Samples were collected before and after the first session (acute) and after eight weeks (chronic).

    Time frame: Baseline, immediately after the first session, and 48 hours after the last session (week 8)

  7. Change in Serum Cortisol

    Serum levels of cortisol measured using commercial chemiluminescence immunoassay kits. Samples were collected before and after the first session (acute) and after eight weeks (chronic).

    Time frame: Baseline, immediately after the first session, and 48 hours after the last session (week 8)

  8. Change in Serum IGF-1

    Serum levels of insulin-like growth factor-1 (IGF-1) measured using commercial chemiluminescence immunoassay kits. Samples were collected before and after the first session (acute) and after eight weeks (chronic).

    Time frame: Baseline, immediately after the first session, and 48 hours after the last session (week 8)

  9. Change in Serum Progesterone

    Serum levels of progesterone measured using commercial chemiluminescence immunoassay kits. Samples were collected before and after the first session (acute) and after eight weeks (chronic) to verify menstrual cycle phase.

    Time frame: Baseline, immediately after the first session, and 48 hours after the last session (week 8)

  10. Change in Serum C-Reactive Protein (CRP)

    Serum levels of C-reactive protein (CRP), an inflammatory marker, measured using an enhanced turbidimetric assay. Samples were collected before and after the first session (acute) and after eight weeks (chronic).

    Time frame: Baseline, immediately after the first session, and 48 hours after the last session (week 8)

07

Study locations

1 site
  • Faculty of Sport Sciences, University of Birjand
    Birjand, South Khorasan Province 9717434765, Iran
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 25, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07785778
Lead sponsor
Birjand University of Medical Sciences
Responsible party
Mohsen mohammadnia ahmadi (Assistant professor, Birjand University of Medical Sciences) — Principal investigator
First posted
Aug 25, 2026
Start date
Nov 20, 2022
Primary completion
Dec 20, 2022
Completion
Dec 30, 2022
Last update
Aug 25, 2026

Study contacts

Mohsen Mohammadnia Ahmadi, PhD
principal investigator · university of birjand

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion